Market Overview:
The global radiation oncology market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The market is segmented by type, application and region. By type, the market is segmented into external beam radiation therapy (EBRT) and brachytherapy. EBRT dominates the global radiation oncology market with a share of more than 60%. By application, blood cancer (leukaemia), breast cancer, gastrointestinal cancer, respiratory/lung cancer, skin cancer and other cancers are the major segments of the global radiation oncology market. Leukaemia dominates the blood cancer applications with a share of more than 50%. Breast Cancer dominates the female reproductive system cancers applications with a share of more than 30%. Gastrointestinal Cancer dominates gastrointestinal system cancers applications with a share of more than 25%. Respiratory/Lung Cancer dominates respiratory system cancers applications with a share in excess of 30%. Skin Cancer is expected to be one of fastest growing segments during forecast period owing to increasing incidence rates for skin carcinomas across world.
Product Definition:
Radiation oncology is the branch of medicine that uses radiation to treat cancer. Radiation therapy destroys cancer cells by damaging their DNA. It can be used to treat cancers that have spread throughout the body (metastatic cancer) or tumors that are only in one area.
External Beam Radiation Therapy (EBRT):
External Beam Radiation Therapy (EBRT) is a type of radiation therapy that delivers high doses of radiation to the cancerous cells with the use of external devices like beams, tubes or waves. EBRT can be used for both curative and palliative treatment. The major factor driving the growth in this market includes increasing adoption due to advantages such as accuracy, precision and convenience over conventional methods.
Brachytherapy:
Brachytherapy is the practice of placing radioactive materials inside a patient's body. The most common form of brachytherapy involves placing sources in the prostate, lungs, liver or breast area. Brachytherapy can be used with external beam radiation therapy (EBRT), which makes it more effective and efficient for use in combination with other forms of cancer treatment such as chemotherapy and/or surgery.
Application Insights:
The blood cancer segment dominated the market in 2017 and is expected to witness significant growth over the forecast period. This can be attributed to increasing incidence of blood cancers, such as acute lymphoblastic leukemia (ALL) and haematological malignancies.
In 2017, ALL accounted for around 54% of total revenue generated through the sale of EBRT systems. Increasing R&D activities pertaining to targeted therapy and immunotherapy are anticipated to boost product demand in near future. In addition, introduction of advanced treatment techniques such as proton therapy is expected to drive growth further over the forecast period. However, high cost associated with these treatments may act as a restraint for its adoption in developing regions like Asia Pacific during future phases of development.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of major players, high adoption rate of advanced technologies, and favorable reimbursement policies. For instance, as per the National Cancer Institute (NCI), in 2016, radiation oncology was one of the most commonly diagnosed cancers at NCI-designated cancer centers across North America with an estimated 9 out of 10 patients receiving care at a cost exceeding 0K. In addition to this, according to NCI’s 2018 estimates Brachytherapy is used for more than 50% treatment plans across North American hospitals that offer brachytherapy services compared with 35% five years ago.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to increasing healthcare spending by governments and private organizations along with rising awareness about early diagnosis among population groups especially in developing countries such as India & China & South Korea etc.
Growth Factors:
- Increasing incidence of cancer: The increasing incidence of cancer is the major growth driver for radiation oncology market. According to the World Health Organization (WHO), there were 14 million new cases of cancer and 8.2 million deaths from cancer in 2012 worldwide, and it is estimated that these numbers will increase to 21 million new cases and 13 million deaths by 2030. This will create a huge demand for radiation oncology services, which will drive the growth of this market.
- Rising awareness about radiation therapy: There is a growing awareness among people about radiation therapy as an effective treatment option for various types of cancers. This has led to an increase in the number of people opting for radiation therapy, thereby driving the growth of this market.
- Technological advancements in radiotherapy equipment: The technological advancements in radiotherapy equipment are leading to better outcomes with fewer side effects associated with radiation therapy treatments. This is encouraging more people to opt for radiotherapy as their preferred mode of treatment, thereby propelling the growth of this market..
Scope Of The Report
Report Attributes
Report Details
Report Title
Radiation Oncology Market Research Report
By Type
External Beam Radiation Therapy (EBRT), Brachytherapy
By Application
Blood Cancer (Leukaemia), Breast Cancer, Gastrointestinal Cancer, Respiratory/Lung Cancer, Skin Cancer, Other Cancers
By Companies
Accuray, C. R. Bard, Elekta, IBA Worldwide, Varian Medical Systems, Carl Zeiss Meditec, iCAD, IsoRay, Mevion Medical Systems, Nordion, NTP Radioisotopes, Toshiba Medical Systems
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
245
Number of Tables & Figures
172
Customization Available
Yes, the report can be customized as per your need.
Global Radiation Oncology Market Report Segments:
The global Radiation Oncology market is segmented on the basis of:
Types
External Beam Radiation Therapy (EBRT), Brachytherapy
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Blood Cancer (Leukaemia), Breast Cancer, Gastrointestinal Cancer, Respiratory/Lung Cancer, Skin Cancer, Other Cancers
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Accuray
- C. R. Bard
- Elekta
- IBA Worldwide
- Varian Medical Systems
- Carl Zeiss Meditec
- iCAD
- IsoRay
- Mevion Medical Systems
- Nordion
- NTP Radioisotopes
- Toshiba Medical Systems
Highlights of The Radiation Oncology Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- External Beam Radiation Therapy (EBRT)
- Brachytherapy
- By Application:
- Blood Cancer (Leukaemia)
- Breast Cancer
- Gastrointestinal Cancer
- Respiratory/Lung Cancer
- Skin Cancer
- Other Cancers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Radiation Oncology Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Radiation oncology is a specialty that treats cancer with radiation therapy. Radiation therapy uses high-energy beams of particles, such as photons (light) or electrons, to damage the cells in the body that have cancer.
Some of the major players in the radiation oncology market are Accuray, C. R. Bard, Elekta, IBA Worldwide, Varian Medical Systems, Carl Zeiss Meditec, iCAD, IsoRay, Mevion Medical Systems, Nordion, NTP Radioisotopes, Toshiba Medical Systems.
The radiation oncology market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Radiation Oncology Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Radiation Oncology Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Radiation Oncology Market - Supply Chain
4.5. Global Radiation Oncology Market Forecast
4.5.1. Radiation Oncology Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Radiation Oncology Market Size (000 Units) and Y-o-Y Growth
4.5.3. Radiation Oncology Market Absolute $ Opportunity
5. Global Radiation Oncology Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Radiation Oncology Market Size and Volume Forecast by Type
5.3.1. External Beam Radiation Therapy (EBRT)
5.3.2. Brachytherapy
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Radiation Oncology Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Radiation Oncology Market Size and Volume Forecast by Application
6.3.1. Blood Cancer (Leukaemia)
6.3.2. Breast Cancer
6.3.3. Gastrointestinal Cancer
6.3.4. Respiratory/Lung Cancer
6.3.5. Skin Cancer
6.3.6. Other Cancers
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Radiation Oncology Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Radiation Oncology Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Radiation Oncology Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Radiation Oncology Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Radiation Oncology Demand Share Forecast, 2019-2029
9. North America Radiation Oncology Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Radiation Oncology Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Radiation Oncology Market Size and Volume Forecast by Application
9.4.1. Blood Cancer (Leukaemia)
9.4.2. Breast Cancer
9.4.3. Gastrointestinal Cancer
9.4.4. Respiratory/Lung Cancer
9.4.5. Skin Cancer
9.4.6. Other Cancers
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Radiation Oncology Market Size and Volume Forecast by Type
9.7.1. External Beam Radiation Therapy (EBRT)
9.7.2. Brachytherapy
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Radiation Oncology Demand Share Forecast, 2019-2029
10. Latin America Radiation Oncology Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Radiation Oncology Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Radiation Oncology Market Size and Volume Forecast by Application
10.4.1. Blood Cancer (Leukaemia)
10.4.2. Breast Cancer
10.4.3. Gastrointestinal Cancer
10.4.4. Respiratory/Lung Cancer
10.4.5. Skin Cancer
10.4.6. Other Cancers
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Radiation Oncology Market Size and Volume Forecast by Type
10.7.1. External Beam Radiation Therapy (EBRT)
10.7.2. Brachytherapy
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Radiation Oncology Demand Share Forecast, 2019-2029
11. Europe Radiation Oncology Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Radiation Oncology Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Radiation Oncology Market Size and Volume Forecast by Application
11.4.1. Blood Cancer (Leukaemia)
11.4.2. Breast Cancer
11.4.3. Gastrointestinal Cancer
11.4.4. Respiratory/Lung Cancer
11.4.5. Skin Cancer
11.4.6. Other Cancers
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Radiation Oncology Market Size and Volume Forecast by Type
11.7.1. External Beam Radiation Therapy (EBRT)
11.7.2. Brahytherapy
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Radiation Oncology Demand Share, 2019-2029
12. Asia Pacific Radiation Oncology Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Radiation Oncology Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Radiation Oncology Market Size and Volume Forecast by Application
12.4.1. Blood Cancer (Leukaemia)
12.4.2. Breast Cancer
12.4.3. Gastrointestinal Cancer
12.4.4. Respiratory/Lung Cancer
12.4.5. Skin Cancer
12.4.6. Other Cancers
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Radiation Oncology Market Size and Volume Forecast by Type
12.7.1. External Beam Radiation Therapy (EBRT)
12.7.2. Brachytherapy
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Radiation Oncology Demand Share, 2019-2029
13. Middle East & Africa Radiation Oncology Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Radiation Oncology Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Radiation Oncology Market Size and Volume Forecast by Application
13.4.1. Blood Cancer (Leukaemia)
13.4.2. Breast Cancer
13.4.3. Gastrointestinal Cancer
13.4.4. Respiratory/Lung Cancer
13.4.5. Skin Cancer
13.4.6. Other Cancers
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Radiation Oncology Market Size and Volume Forecast by Type
13.7.1. External Beam Radiation Therapy (EBRT)
13.7.2. Brachytherapy
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Radiation Oncology Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Radiation Oncology Market: Market Share Analysis
14.2. Radiation Oncology Distributors and Customers
14.3. Radiation Oncology Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Accuray
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. C. R. Bard
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Elekta
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. IBA Worldwide
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Varian Medical Systems
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Carl Zeiss Meditec
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. iCAD
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. IsoRay
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Mevion Medical Systems
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Nordion
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. NTP Radioisotopes
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Toshiba Medical Systems
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
